1. Home
  2. GRCE vs MOVE Comparison

GRCE vs MOVE Comparison

Compare GRCE & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRCE
  • MOVE
  • Stock Information
  • Founded
  • GRCE 2002
  • MOVE 2018
  • Country
  • GRCE United States
  • MOVE United States
  • Employees
  • GRCE N/A
  • MOVE N/A
  • Industry
  • GRCE
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GRCE
  • MOVE Health Care
  • Exchange
  • GRCE NYSE
  • MOVE Nasdaq
  • Market Cap
  • GRCE 30.9M
  • MOVE 25.9M
  • IPO Year
  • GRCE N/A
  • MOVE 2021
  • Fundamental
  • Price
  • GRCE $3.31
  • MOVE $3.52
  • Analyst Decision
  • GRCE
  • MOVE Buy
  • Analyst Count
  • GRCE 0
  • MOVE 1
  • Target Price
  • GRCE N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • GRCE 44.3K
  • MOVE 61.3K
  • Earning Date
  • GRCE 11-13-2024
  • MOVE 11-14-2024
  • Dividend Yield
  • GRCE N/A
  • MOVE N/A
  • EPS Growth
  • GRCE N/A
  • MOVE N/A
  • EPS
  • GRCE N/A
  • MOVE N/A
  • Revenue
  • GRCE N/A
  • MOVE $852,000.00
  • Revenue This Year
  • GRCE N/A
  • MOVE N/A
  • Revenue Next Year
  • GRCE N/A
  • MOVE $443.49
  • P/E Ratio
  • GRCE N/A
  • MOVE N/A
  • Revenue Growth
  • GRCE N/A
  • MOVE N/A
  • 52 Week Low
  • GRCE $1.98
  • MOVE $3.01
  • 52 Week High
  • GRCE $3.60
  • MOVE $14.70
  • Technical
  • Relative Strength Index (RSI)
  • GRCE N/A
  • MOVE 36.00
  • Support Level
  • GRCE N/A
  • MOVE $3.76
  • Resistance Level
  • GRCE N/A
  • MOVE $4.28
  • Average True Range (ATR)
  • GRCE 0.00
  • MOVE 0.49
  • MACD
  • GRCE 0.00
  • MOVE 0.00
  • Stochastic Oscillator
  • GRCE 0.00
  • MOVE 31.75

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: